Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN105085373B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105085373B details a novel purification method for Apremilast, achieving 99.9% purity via single crystallization, offering significant supply chain and cost advantages for pharmaceutical manufacturers.